Dr Dhruv Parekh, Associate Professor in Respiratory Medicine, has been accepted onto the 2022 cohort of the Academy of Medical Sciences Future Leaders Programme
Birmingham scientists have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response in the spinal cord.
Dr Kanta Kumar together with rheumatology teams across the UK has played a key role in the Healthcare Quality Improvement Partnership report.
The University of Birmingham's Institute of Inflammation and Ageing has been awarded four major grants.
Older patients in hospitals across China took part in a major multi-centre open-label randomised clinical trial that showed there was no difference in post-operative delirium in older people with a hip fracture.
The University of Birmingham today announces the launch of five new major studies aimed at improving the prevention, treatment and management of type 1 diabetes – with a particular focus on children and young adults.
A proof-of-concept trial has identified a drug that may offer benefit some patients hospitalised with COVID-19 pneumonia.
So-called 'telemedicine' is less diagnostically accurate than in-person consultations and could increase health inequalities and barriers to accessing appropriate care.
New drug treatment regimen, using belimumab soon after rituximab, reduced a disease-related autoantibody and severe disease flares in lupus patients.
Scientists at the University of Birmingham have led a study which has identified a new specific population of cells that plays a key role in the affect arthritis has on the body and the subsequent pain felt by patients.
A new project has been launched in partnership with the University of Birmingham aiming to address racial and ethical health inequalities using artificial intelligence.
Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.